SELLAS Life Sciences (SLS) Non-Current Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Non-Current Debt data on file, last reported at $1.2 million in Q1 2018.

• Quarterly Non-Current Debt changed N/A year-over-year to $1.2 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.2 million (changed N/A YoY) and the FY2017 annual result came in at $2.6 million, changed N/A from the prior year.
• Non-Current Debt declined to $1.2 million in Q1 2018 per SLS's latest filing, from $2.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $6.9 million in Q1 2014 and bottomed at $1.2 million in Q1 2018.
• The 4-year median for Non-Current Debt is $3.5 million (2015), against an average of $3.8 million.
• The widest annual swing landed in 2014, when Non-Current Debt sank 36.16%; it then sank 70.06% in 2015.
• Tracing SLS's Non-Current Debt over 4 years: stood at $4.5 million in 2014, then plunged by 66.03% to $1.5 million in 2015, then soared by 71.1% to $2.6 million in 2017, then slumped by 55.96% to $1.2 million in 2018.
• Per Business Quant, the three latest SLS Non-Current Debt figures stand at $1.2 million (Q1 2018), $2.6 million (Q4 2017), and $1.5 million (Q3 2015).

Peer Comparison